Oncology ASCO26: AI supercharging gene-based cancer detection, with D... Pharmaphorum caught up with Caris Life Science's David Spetzler to talk about how agentic AI is empowering whole genome sequencing in cancer detection
R&D Whole-genome sequencing in the UK and Europe, with Mark Robi... Whole-genome sequencing provides an unbiased and complete view of the human genome and enables the discovery of genetic variation.
Oncology ESMO 2024 – Today’s oncological roots are branching What could a tree possibly reveal about the European Society for Medical Oncology (ESMO)?
Oncology Sponsored Case Study: MGI and Alacris Theranostics As World Cancer Day approached this year, the increasing focus on precision oncology continued apace.
News UK study backs whole-genome screening for cancer care A major new study in the UK has shown that combining whole-genome sequencing (WGS) and real-world clinical data at a national scale can help deliver tailored, personalised
Partner Content Partner Content 6th Annual Next Generation Sequencing USA Congress 2 days, 350+ end users, 80+ case studies
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.